GC Pharma selected for KDCA's mRNA vaccine development project, aiming to secure domestic platform with 505.2 billion won investment by 2028
#YonhapInfomax #GCPharma #MRNAVaccine #KDCA #VaccineDevelopment #PandemicPreparedness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=59197
GC Pharma Selected for KDCA's 'mRNA Vaccine Development Support Project'

GC Pharma selected for KDCA's mRNA vaccine development project, aiming to secure domestic platform with 505.2 billion won investment by 2028

Yonhap Infomax

Discover how mRNA vaccines do more than fight COVID-19—they reprogram your immune system for lasting defense. #mRNAVaccine #ImmuneMemory #HealthInnovation

https://geekoo.news/mrna-vaccines-enhance-immune-memory-beyond-expectations/

mRNA Vaccines Enhance Immune Memory Beyond Expectations | Geekoo

Emerging research reveals that mRNA COVID-19 vaccines induce lasting epigenetic changes in the innate immune system, enhancing the body's preparedness against future infections and showcasing broader immunological benefits than previously recognized.

Geekoo

A melanoma #vaccine called mrna-4157, developed by Moderna and Merck, that is performing well in trials

Cannot wait to see the anti-vax folks heads explode when they have to choose between a vaccine or #cancer

#mrna #mrnavaccine

Researchers are excited about a groundbreaking combination therapy that integrates oncolytic viruses with T cells or mRNA vaccines, significantly enhancing antitumor effects! 🌟 This innovative approach transforms the tumor microenvironment, boosting immune responses and potentially reshaping cancer treatment. 💪✨ #CancerResearch #OncolyticVirus #mRNAVaccine #Immunotherapy #AntitumorEffects

https://www.nature.com/articles/s41392-024-01824-1.pdf

First UK Lung Cancer Patient receives mRNA vaccine BNT116  
BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such...........
#BNT116 #Cancer #DNAVaccine #Lungcancer #LungVax #mRNAVaccine #nonsmallcelllungcancer #NSCLC #UK #Vaccine
Umesh Prasad

https://www.scientificeuropean.co.uk/medicine/first-uk-lung-cancer-patient-receives-mrna-vaccine-bnt116/

First UK Lung Cancer Patient receives mRNA vaccine BNT116  

BNT116 and LungVax are nucleic acid lung cancer vaccine candidates – the former is based on mRNA technology similar to “COVID-19 mRNA vaccines” such as BN

Scientific European
the #MRNAvaccine makers should sue the crap out of these creeps posthaste.

"How mRNA vaccines could be personalized cancer cures"

Personalized?

 

"YAL, your mRNA vaccine will have a lot of foot in it."

"Why?"

"To better kick your cancer in the ass."

"I approve. Can you also add a bit of nuclear bomb into it?"

"Sure, but why?"

"I also want to nuke that bastard."

"Fair enough."

 

(Yes, I'm a cancer survivor. This bit is not satire.)

#mRNAVaccine #cancer #CancerSurvivor #satire

https://www.axios.com/2024/05/07/how-mrna-vaccines-could-be-personalized-cancer-cures

How mRNA vaccines could be personalized cancer cures

A growing pipeline of vaccine is aimed at tackling some of the world's most pernicious forms of cancer.

Axios
mRNA vaccine for pancreatic cancer — excellent long-term results https://www.skepticalraptor.com/skepticalraptorblog.php/mrna-vaccine-for-pancreatic-cancer-excellent-long-term-results/#mRNAVaccine technology is going to be one of the leading technologies for cancer treatments, including #PancreaticCancer, going forward. If it can make a meaningful dent in the course of pancreatic cancer, it may well become one of the primary tools for oncologists in treating this pernicious disease.”
mRNA vaccine for pancreatic cancer — excellent long-term results

Recent long-term clinical trial data reveals the mRNA vaccine, cevumeran, elicits a lasting immune response in pancreatic cancer patients.

Skeptical Raptor
Persistence of immune responses of a self-amplifying RNA #COVID19vaccine (ARCT-154) versus #BNT162b2 - The Lancet Infectious Diseases https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2824%2900060-4/fulltext “a booster dose of the novel #mRNAVaccine, #ARCT154, a self-amplifying mRNA (#saRNA) vaccine based on the #SARSCoV2 D614G variant (B.1), induced superior immunogenicity than BNT162b2 (Comirnaty; Pfizer–BioNTech) in BNT162b2-primed adults 1 month after administration.”